Evaluation of Serratia Peptidase in Acute or Chronic Inflammation of Otorhinolaryngology Pathology: A Multicentre, Double-Blind, Randomized Trial versus Placebo

First Published September 1, 1990 Research Article Find in PubMed

Authors

1
 
Institute of Clinical Otorhinolaryngology, University of Naples, Naples, Italy
by this author
, 2
 
Ear, Nose and Throat Department, ‘Gradenigo’ Hospital, Turin, Italy
by this author
, 3
 
Ear, Nose and Throat Department, ‘Villa Sofia’ Hospital, Palermo, Italy
by this author
,
4
 
Ear Nose and Throat Department, Treviso Regional Hospital, Treviso, Italy
by this author
, 5
 
Ear, Nose and Throat Department, ‘E. Fornaroli’ Hospital, Magenta, Italy
by this author
, 6
 
Ear, Nose and Throat Department, Lucca Hospital, Lucca, Italy
by this author
, 7
 
Ear, Nose and Throat Department, Civil Hospital, Lecce, Italy
by this author
, 8
 
Ear, Nose and Throat Department, ‘Madonna del Soccorso’ Hospital, San Benedetto del Tronto, Italy
by this author
...
First Published Online: June 25, 2016

The efficacy and tolerability of Serratia peptidase were evaluated in a multicentre, double-blind, placebo-controlled study of 193 subjects suffering from acute or chronic ear, nose or throat disorders. Treatment lasted 7–8 days, with the drug or placebo being administered at a rate of two tablets three times a day. After 3–4 days' treatment, significant symptom regression was observed in peptidase-treated patients. There was also a significant reduction in symptoms after 7 – 8 days for patients in both treatment groups but the response was more marked in those patients receiving the active drug. Statistical comparison between the two groups confirmed the greater efficacy and rapid action of the peptidase against all the symptoms examined at both stages. Tolerance was found to be very good and similar for both groups. It is concluded that Serratia peptidase has anti-inflammatory, anti-oedemic and fibrinolytic activity and acts rapidly on localized inflammation.

1. Conticello, S, Malannino, H, Serra, A: La serratiopeptidasi in ORL. Nuova Clin ORL 1979; 31: 1520.
Google Scholar
2. Villari, G, Ripa, G, De Maio, V: Modificazioni delle caratteristiche reologiche del muco nasale in soggetti affetti da patologia rino-sinusale dopo trattamento con Serratiopeptidasi. Valsalva 1984; 60: 149150.
Google Scholar
3. Pallotti, S, Agostini, M, D'Este, S: Valutazione dell'attivitá fibrinolitica della Serratiopeptidasi. Farmaci 1982; 3: 163173.
Google Scholar
4. Kakinuma, A, Moriya, N, Kawahara, K: Regression of fibrinolysis in scalded rats by administration of Serratia protease. Biochem Pharmacol 1982; 31: 28612866.
Google Scholar | Crossref | Medline | ISI
5. Marty, M : Enzymotherapie anti-inflammatoire à l'aide de la serrapeptase: resultats cliniques en traumatologie et en ORL. C R Therapeut 1985; 3: 919.
Google Scholar
6. Odagiri, J, Ohga, T: Clinical applications of Danzen in sinusitis. Med Consult New Remedy 1979; 6: 201209.
Google Scholar
7. Yamazaki, H, Tsuji, H: Anti-inflammatory activity of TSP, a protease produced by a strain of Serratia. Folia Pharmacol Japon 1967; 63: 302314.
Google Scholar | Crossref | Medline
8. Elies, W, Mevissen, M, Rücker, H-J: Akute und subakute Entzundungen der Nasennebenhölen. Z Allmeinmed 1987; 4: 9295.
Google Scholar
9. Harada, Y : Clinical efficacy of Danzen on buccal swelling after radical operation for chronic sinusitis. Igaku Ayumi 1982; 123: 768778.
Google Scholar
10. Matsudo, A, Taniguchi, T, Hiratsuta, M: Effect of serratiopeptidase (Danzen) on inflammatory edema following operation for thyroid disease. Med Consult New Remedy 1981; 18: 171175.
Google Scholar
11. Mizukoshi, D, Saito, H, Nishimura, T: A double-blind clinical study of Dasen tablets in the treatment of chronic sinusitis. Igaku Aymi 1979; 109: 5062.
Google Scholar
12. Cocchiola, D, Beltrami, V: Osservazioni cliniche sul trattomento in doppio cieco con ‘serratiopeptidasi’ nella rinite perenne, nelle rinite cronica riacutizzata con sinusopatia, nella bronchite cronica riacutizzata. Riv Patol Clin Tubercol Pneumol 1985; 56: 509515.
Google Scholar
13. Fujitani, T, Shimizo, Y, Iuoguchi, J: Effect of anti-inflammatory agent on transfer of antibiotics to the maxillary sinus mucosa in chronic sinusitis. Otorhinolaryngol Clin North Am 1976; 66: 557565.
Google Scholar
14. Passali, E, De Seta, E, Bianchini Ciampoli, M: Trattamento dell'otite media secretiva con serratiopeptidasi: studio clinico randomizzato in doppio cieco versus placebo. Pediatr Oggi 1983; 3: 367378.
Google Scholar
15. Paparella, P, Brizio, AM, Carlucci, NA: Serratia peptidase and acute phase protein behaviour following vaginal hysterectomy. Curr Ther Res 1989; 45: 664676.
Google Scholar | ISI
16. Villari, G, De Maio, V, Motta, G: Modificazioni delle caratteristiche reologiche del muco tracheo-bronchiale e della funzionalità respiratoria nei soggetti laringectomizzati prima e dopo trattamento con serratiopeptidasi. Otorinolaringologia 1983; 33: 297306.
Google Scholar

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Access Options

    My Account

    Welcome
    You do not have access to this content.

    Chinese Institutions / 中国用户

    Click the button below for the full-text content

    请点击以下获取该全文

    Institutional Login

    Purchase Content

    24 hours online access to download content

    Added to Cart

    Cart is full

    There is currently no price available for this item in your region.

    Research off-campus without worrying about access issues. Find out about Lean Library here


Purchase

IMR-article-ppv for GBP23.00
IMR-article-ppv for $30.00